abstract |
The present invention is directed to novel 1,2,4-thiadiazole derivatives of the formula (II) wherein R1, R2 and R4, are ring containing radicals, useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders. |